Hi Oz
In the last 10 years only one regulator has approved the Oncosil device. And even then with no public reimbursement. What does that tell you?
TGA application was withdrawn.
FDA application for bile duct has no trial data.
GBA has not finalised its approval even though it’s been now over 2 years with them.
Not one commercial sale in the UK even though it was launched in the UK nearly 5 years ago.
No longer any sales from NZ despite there being some sales in the past.
Quarterly sales of less than 100K with $3 million of costs per quarter.
What does this tell you?
Ann: Two more PANCOSIL Trial treatments using OncoSil device, page-114
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.66M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.5¢ | $4.47K | 886.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6296690 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 22890532 | 25 |
View Market Depth
| Last trade - 14.42pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
0.5¢ |
Change
0.000 ( 11.1 %) |
||||
| Open | High | Low | Volume | ||
| 0.5¢ | 0.5¢ | 0.5¢ | 2050000 | ||
| Last updated 14.42pm 14/06/2024 ? | |||||
| OSL (ASX) Chart |